GSK racked up 1.4 billion pounds ($1.9 billion) in COVID-related sales in 2021, largely for antibody drug sotrovimab, Read More
GSK’s COVID-related sales close to $2 billion, profit boost to wane in 2022
Reading Time: < 1 minute
GSK racked up 1.4 billion pounds ($1.9 billion) in COVID-related sales in 2021, largely for antibody drug sotrovimab, Read More